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Background: Previous studies suggest that left ventricular (LV) global longitudinal strain (GLS) analysis by 2-dimensional speckle tracking 
echocardiography is useful to detect subclinical LV dysfunction. However, no prior study has used GLS to assess cardiac allograft function prior to 
transplantation or to compare the function of a cardiac allograft in donors and subsequent recipients.
Methods: We retrospectively analyzed echocardiograms in 37 heart donor-recipient pairs transplanted at Duke University Medical Center from 
2000 to 2013. Assessments of allograft LV systolic function by LV ejection fraction (LVEF) and GLS were performed pre-explantation in donors and 
serially in corresponding recipients.
results: Donors (mean age 35 ± 14 years) had a mean LVEF of 55 ± 4%. Mean graft ischemic time was 106 ± 31 minutes. Mean donor GLS was 
-15 ± 3%; 67% of donor hearts had GLS below -16%, the institutional lower limit of normal (LLN) compared to 4% below the LLN for LVEF (i.e., 50%). 
After transplant, allograft function by mean GLS was further attenuated at 6 weeks (-13 ± 3%) before recovering to pre-transplant levels in extended 
follow up. There was no relationship between GLS and biopsy-detected cellular rejection. Mean LVEF among recipients remained ≥ 55% throughout 
follow up (see figure).
conclusion: GLS demonstrates allograft LV dysfunction in donors and recipients that is not detected by LVEF. The clinical implications of 
subclinical allograft dysfunction detected by GLS require further study.
